Hormonal therapy after stem cell transplantation and risk of veno-occlusive disease

Blood. 1999 May 1;93(9):3154.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hormone Replacement Therapy*
  • Humans
  • Leukemia / therapy
  • Leuprolide / therapeutic use*
  • Lymphoma / therapy
  • Middle Aged
  • Premenopause
  • Risk Factors
  • Uterine Hemorrhage / etiology
  • Uterine Hemorrhage / prevention & control*
  • Vascular Diseases / prevention & control*

Substances

  • Leuprolide